Suppr超能文献

3-氰基-6-(5-甲基-3-吡唑并氨基)吡啶(第二部分):一种极光激酶和微管蛋白聚合的双重抑制剂。

3-Cyano-6-(5-methyl-3-pyrazoloamino) pyridines (Part 2): A dual inhibitor of Aurora kinase and tubulin polymerization.

作者信息

Morioka Masahiko

机构信息

R&D, Marketing & Business Planning Division, CXS Corporation, 22 Yamashita-cho, Naka-ku, Yokohama 231-0023, Japan.

出版信息

Bioorg Med Chem Lett. 2016 Dec 15;26(24):5860-5862. doi: 10.1016/j.bmcl.2016.11.020. Epub 2016 Nov 12.

Abstract

A new class of a dual inhibitor of Aurora kinase and tubulin polymerization was created by introducing various substituted phenoxyethylamino or pyridyloxyethylamino groups to the 2-position of 3-cyano-4-methyl-6-(5-methyl-3-pyrazoloamino)-pyridine. Compound 3g exhibited Aurora kinase inhibition, excellent protein kinase selectivity to Aurora kinase in comparison with 66 other kinases, inhibition of phosphorylation of Ser10 of histone H3 as an Aurora kinase inhibitor, inhibition of tubulin polymerization in vitro, good cell membrane permeability, and a good PK profile. Therefore compound 3g was effective in some antitumor mouse models at a dose of 30mg/kgpoqd.

摘要

通过将各种取代的苯氧基乙氨基或吡啶氧基乙氨基基团引入到3-氰基-4-甲基-6-(5-甲基-3-吡唑啉氨基)-吡啶的2-位,合成了一类新型的Aurora激酶和微管蛋白聚合双重抑制剂。化合物3g表现出Aurora激酶抑制活性,与其他66种激酶相比,对Aurora激酶具有优异的蛋白激酶选择性,作为Aurora激酶抑制剂可抑制组蛋白H3的Ser10磷酸化,在体外抑制微管蛋白聚合,具有良好的细胞膜通透性和良好的药代动力学特征。因此,化合物3g在一些抗肿瘤小鼠模型中以30mg/kg口服每日一次的剂量有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验